English
Sanofi Consumer Healthcare India Q2 Results
- BSE: 544250
- NSE: SANOFICONR
- ISIN: INE0UOS01011
- Sector: Biotechnology & Drugs
BSE
4,050
-47.15 (-1.15%)
-47.15 (-1.15%)Volume4.00
Updated: Fri 23 Jan, 2026 | 09:51:07
NSE
4,065.90-59.90 (-1.45%)
-59.90 (-1.45%)Volume861.00
Updated: Fri 23 Jan, 2026 | 11:11:07
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Sanofi Consumer Healthcare India Q2 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 147.10 | 110.60 | 33.00% | 126.20 | 16.56% |
| Depreciation/ Amortization | 3.00 | 2.00 | 50.00% | 1.10 | 172.73% |
| Operating Income | 73.80 | 62.00 | 19.03% | 38.20 | 93.19% |
| Net Income | 60.70 | 50.00 | 21.40% | 29.00 | 109.31% |
| Other Operating Expenses Total | 57.50 | 40.20 | 43.03% | 30.50 | 88.52% |
| Net Income Before Taxes | 78.90 | 66.80 | 18.11% | 38.90 | 102.83% |
| Total Revenue | 220.90 | 172.60 | 27.98% | 164.40 | 34.37% |
| Selling/ General/ Admin Expenses Total | 32.00 | 29.60 | 8.11% | 24.80 | 29.03% |
| Diluted Normalized EPS | 24.15 | 21.71 | 11.26% | 20.46 | 18.07% |
EQUITY QUICK LINKS
FROM MARKETS
RELATED LINKS
- Sanofi Consumer Healthcare India share price
- Sanofi Consumer Healthcare India Profit Loss
- Sanofi Consumer Healthcare India Balance Sheet
- Sanofi Consumer Healthcare India Cashflow
- Sanofi Consumer Healthcare India Q1 Results
- Sanofi Consumer Healthcare India Q3 Results
- Sanofi Consumer Healthcare India Q4 Results
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.